US FDA Advisory Committee Formats Can Spur Unhealthy Dynamics – Califf

 
• By Sarah Karlin-Smith
  
five people with same "thinking" bubble
FDA thinking about how to curtail problematic group dynamics during advisory panels. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from United States

More from North America